Table 4.

Correlation of mRNA expression of SOCS family members with tumor stages of OC patients

Gene	Stages	Case-low1	Case-high2	HR (95% CI)	p-value
SOCS1	1 + 2	91	44	0.53 (0.2-1.4)	0.19
	3 + 4	585	635	0.82 (0.71-0.95)	0.0094**
SOCS2	1 + 2	30	53	4.26 (0-inf)	0.0015**
	3 + 4	154	333	0.87 (0.68-1.1)	0.25
SOCS3	1 + 2	54	29	0.28 (0.06-1.25)	0.074
	3 + 4	363	124	0.81 (0.63-1.06)	0.13
SOCS4	1 + 2	61	22	1.76 (0.62-4.98)	0.28
	3 + 4	331	156	1.13 (0.89-1.44)	0.33
SOCS5	1 + 2	68	67	1.57 (0.71-3.47)	0.26
	3 + 4	460	760	1.49 (1.27-1.75)	5.4e-07**
SOCS6	1 + 2	21	62	0.23 (0.08-0.64)	0.0022**
	3 + 4	216	271	1.33 (1.06-1.67)	0.015*
SOCS7	1 + 2	30	53	0.46 (0.17-1.28)	0.13
	3 + 4	257	230	1.26 (1.01-1.58)	0.045*
CIS	1 + 2	34	49	0.35 (0.12-1)	0.041*
	3 + 4	354	133	1.28 (1.01-1.63)	0.041*

¹Cases-low: patient number-low expression of the corresponding gene.

²Cases-high: patient number-high expression of the corresponding gene.

^* P < 0.05;

^** P < 0.01.